Published in Br J Cancer on September 02, 2008
The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci U S A (2012) 1.92
C5a-regulated CCAAT/enhancer-binding proteins β and δ are essential in Fcγ receptor-mediated inflammatory cytokine and chemokine production in macrophages. J Biol Chem (2011) 1.01
Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma. Nucl Med Mol Imaging (2010) 0.98
Microarray analysis of papillary thyroid cancers in Korean. Korean J Intern Med (2010) 0.98
Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer. Cancer Chemother Pharmacol (2013) 0.87
CCAAT/enhancer-binding protein γ is a critical regulator of IL-1β-induced IL-6 production in alveolar epithelial cells. PLoS One (2012) 0.78
Recent advances in molecular diagnosis of thyroid cancer. J Thyroid Res (2011) 0.78
The transcription factor FOXA2 suppresses gastric tumorigenesis in vitro and in vivo. Dig Dis Sci (2014) 0.77
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk. Sci Rep (2015) 0.77
5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro. Thyroid (2013) 0.77
The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev (1996) 5.71
PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science (2000) 3.87
Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet (1998) 2.75
Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res (2001) 2.53
Iodide transport in the thyroid gland. Biochim Biophys Acta (1993) 1.83
Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood (2005) 1.35
Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo. Clin Cancer Res (2006) 1.32
Identification of 20 genes aberrantly methylated in human breast cancers. Int J Cancer (2005) 1.27
Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha. EMBO J (2001) 1.26
Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status. J Clin Endocrinol Metab (1999) 1.19
Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors. J Clin Endocrinol Metab (2003) 1.17
Molecular basis of thyroid cancer. Endocr Rev (1994) 1.16
Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3. Exp Cell Res (2006) 1.15
A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer. Cancer Res (2004) 1.13
Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Biochem Biophys Res Commun (1997) 1.09
Role of Genes in Endoderm-derived Organs. Trends Endocrinol Metab (1999) 1.07
C/EBP proteins contain nuclear localization signals imbedded in their basic regions. Gene Expr (1997) 1.02
Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis. Biochimie (1999) 1.01
Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the beta-adrenergic receptor. J Clin Endocrinol Metab (1997) 1.01
Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene. BMC Cancer (2005) 0.90
Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells. Cancer Res (2001) 0.89
Expression, hormonal regulation, and subcellular localization of CCAAT/enhancer-binding protein-beta in rat and human thyrocytes. Thyroid (2005) 0.87
Reexpression of thyroid peroxidase in a derivative of an undifferentiated thyroid carcinoma cell line by introduction of wild-type p53. Cancer Res (1996) 0.86
Hepatocyte nuclear factor 3beta participates in the transcriptional regulation of the thyroperoxidase promoter. Biochem Biophys Res Commun (1996) 0.84
Redifferentiation therapy in advanced thyroid cancer. Curr Drug Targets Immune Endocr Metabol Disord (2004) 0.83
Overexpression of TTF-1 and PAX-8 restores thyroglobulin gene promoter activity in ARO and WRO cell lines. Surgery (1998) 0.80
Human p53 gene localized to short arm of chromosome 17. Nature (1986) 4.67
Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A (1987) 4.21
Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science (1978) 3.91
A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med (1999) 3.69
Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci U S A (1998) 3.46
Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med (1994) 3.38
The role of the vitamin D endocrine system in health and disease. N Engl J Med (1989) 3.37
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med (1998) 3.19
Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med (2000) 3.00
Amygdalin (Laetrile): effect on clonogenic cells from human myeloid leukemia cell lines and normal human marrow. Cancer Treat Rep (1980) 2.86
A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol (1972) 2.76
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res (1998) 2.67
Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature (1986) 2.56
Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res (2001) 2.53
Tuberculous meningitis: a 30-year review. Clin Infect Dis (1993) 2.48
Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem (1999) 2.47
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res (1999) 2.38
The nephrotic syndrome associated with secondary syphilis. An immune deposit disease. Am J Med (1970) 2.37
Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med (1973) 2.30
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest (1993) 2.25
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia (2005) 2.15
A potential transcriptional activation element in the p53 protein. Oncogene (1990) 2.07
Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood (1983) 2.01
1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol (1984) 2.01
Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene (2008) 1.97
gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun (1985) 1.97
Human myeloid leukemia cell lines: a review. Blood (1980) 1.96
Absence of WAF1 mutations in a variety of human malignancies. Blood (1994) 1.95
p27/Kip1 mutation found in breast cancer. Cancer Res (1996) 1.94
1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1987) 1.89
Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood (1996) 1.89
Myeloid transcription factor C/EBPepsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils. Blood (1999) 1.88
An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood (1980) 1.86
Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. Am J Surg Pathol (1997) 1.79
Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood (1995) 1.76
Serum human chorionic gonadotropin levels throughout normal pregnancy. Am J Obstet Gynecol (1976) 1.71
Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo. Leukemia (2002) 1.71
Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence and evidence for multiple mRNA species. Nucleic Acids Res (1987) 1.67
Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma. Leukemia (2006) 1.67
Gonadotropins and their subunits: basic and clinical studies. Recent Prog Horm Res (1976) 1.66
Early intervention in psychosis: keeping faith with evidence-based health care. Psychol Med (2009) 1.64
Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys (1997) 1.61
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res (2001) 1.61
25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J Clin Endocrinol Metab (1987) 1.54
Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood (1997) 1.54
Molecular genetic advances in chronic myelogenous leukemia. Ann Intern Med (1990) 1.54
Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem (2001) 1.52
Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood (2001) 1.50
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1). Oncogene (2006) 1.48
DNA aneuploidy in morphologically normal colons from patients with colon cancer. Mod Pathol (1995) 1.48
Effects of anabolic-androgenic steroids on muscular strength. Ann Intern Med (1991) 1.47
First-trimester chorionic gonadotropin measurements as an aid in the diagnosis of early pregnancy disorders. Am J Obstet Gynecol (1978) 1.46
CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest (1999) 1.45
Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines. Cancer Res (1997) 1.44
Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins. Mol Cell Biol (1999) 1.43
Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood (1995) 1.42
APACHE II in surgical lung carcinoma patients. Chest (1990) 1.42
Myeloperoxidase: its structure and expression during myeloid differentiation. Blood (1985) 1.41
Missed opportunities for prevention of tuberculosis in Victoria, Australia. Int J Tuberc Lung Dis (1997) 1.40
Characterization of a novel HTLV-infected cell line. Blood (1984) 1.40
Tumor control probability of nasopharyngeal carcinoma: a comparison of different mathematical models. Int J Radiat Oncol Biol Phys (1997) 1.39
Serum concentrations of two endometrial proteins are not useful for monitoring postmenopausal estrogen/progesterone therapy. Fertil Steril (1990) 1.39
Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood (2000) 1.38
Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res (1984) 1.37
p53 in hematologic malignancies. Blood (1994) 1.37
Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem (2000) 1.37
The value of a hospitalist service: efficient care for the aging population? Chest (2001) 1.36
Regulation of expression of murine transferrin receptor 2. Blood (2001) 1.35
Pathophysiology of acromegaly. Endocr Rev (1983) 1.35
Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res (1981) 1.33
Successful triage of patients referred to a skin lesion clinic using teledermoscopy (IMAGE IT trial). Br J Dermatol (2010) 1.33
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood (1996) 1.33
Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res (1990) 1.33
Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. J Clin Invest (1982) 1.33
p53 mutations in human lung tumors. Cancer Res (1992) 1.33
The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene (2007) 1.32
Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut (2003) 1.32
N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome. Blood (1993) 1.32
Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood (1998) 1.30
Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer. Cancer Res (2000) 1.30
Gamma-interferon induces expression of the HLA-D antigens on normal and leukemic human myeloid cells. Proc Natl Acad Sci U S A (1984) 1.29
Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest (1986) 1.29
Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res (1993) 1.29
A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. Blood (1997) 1.29
Dlk1 in normal and abnormal hematopoiesis. Leukemia (2005) 1.28
Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood (1998) 1.28
Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem (2001) 1.28
Imported malaria treated in Melbourne, Australia: epidemiology and clinical features in 246 patients. J Travel Med (2001) 1.27
Recombinant human TNF alpha stimulates production of granulocyte colony-stimulating factor. Blood (1987) 1.26
Phorbol diester-induced macrophage differentiation of leukemic blasts from patients with human myelogenous leukemia. J Clin Invest (1980) 1.26
Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies. Cancer Res (2001) 1.25
Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest (1995) 1.25
p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression. J Exp Med (1988) 1.24
Regulation of 1,25-dihydroxyvitamin D3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J Clin Endocrinol Metab (1987) 1.24
A combination of calcium ionophore and 12-O-tetradecanoyl-phorbol-13-acetate (TPA) stimulates the growth of purified resting B cells. Scand J Immunol (1985) 1.23